StockData

Nu-Med Plus, Inc. (NUMD) stock

NUMDOTCGold and Silver OresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026Market cap $601.55KP/E –Yield –

Nu-Med Plus operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nu-Med Plus's operating cash flow for the twelve months ending Jun 30, 2026 was -$51.72K. For fiscal 2025 it was -$47.98K. The highest annual figure on record is -$4.43K in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$47.98K–
FY2024Dec 31, 2024-$4.43K–
FY2023Dec 31, 2023-$66.39K–
FY2022Dec 31, 2022-$38.48K–
FY2021Dec 31, 2021-$206.83K–
FY2020Dec 31, 2020-$414.80K–
FY2019Dec 31, 2019-$567.34K–
FY2018Dec 31, 2018-$467.57K–
FY2017Dec 31, 2017-$430.51K–
FY2016Dec 31, 2016-$180.26K–
FY2015Dec 31, 2015-$182.91K–
FY2014Dec 31, 2014-$158.26K–
FY2013Dec 31, 2013-$140.48K–
FY2012Dec 31, 2012-$104.19K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.13K–
Q1 FY2026Mar 31, 2026-$6.38K–
Q4 FY2025Dec 31, 2025-$35.05K–
Q3 FY2025Sep 30, 2025-$11.42K–
Q2 FY2025Jun 30, 2025-$1.51K–
Q1 FY2025Mar 31, 2025$0–
Q4 FY2024Dec 31, 2024-$1.67K–
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024-$2.32K–
Q1 FY2024Mar 31, 2024-$450–
Q4 FY2023Dec 31, 2023-$4.28K–
Q3 FY2023Sep 30, 2023-$18.87K-3104.6%
Q2 FY2023Jun 30, 2023-$23.07K–
Q1 FY2023Mar 31, 2023-$20.17K–
Q4 FY2022Dec 31, 2022-$24.43K–
Q3 FY2022Sep 30, 2022$628–
Q2 FY2022Jun 30, 2022-$2.54K–
Q1 FY2022Mar 31, 2022-$12.14K–
Q4 FY2021Dec 31, 2021-$20.17K–
Q3 FY2021Sep 30, 2021-$40.99K–
Q2 FY2021Jun 30, 2021-$66.43K–
Q1 FY2021Mar 31, 2021-$79.24K–
Q4 FY2020Dec 31, 2020-$71.25K–
Q3 FY2020Sep 30, 2020-$101.02K–
Q2 FY2020Jun 30, 2020-$147.34K–
Q1 FY2020Mar 31, 2020-$95.19K–
Q4 FY2019Dec 31, 2019-$124.67K–
Q3 FY2019Sep 30, 2019-$75.46K–
Q2 FY2019Jun 30, 2019-$120.52K–
Q1 FY2019Mar 31, 2019-$246.70K–
Q4 FY2018Dec 31, 2018-$143.33K–
Q3 FY2018Sep 30, 2018-$142.93K–
Q2 FY2018Jun 30, 2018-$99.55K–
Q1 FY2018Mar 31, 2018-$81.76K–
Q2 FY2017Jun 30, 2017-$89.60K–
Q1 FY2017Mar 31, 2017-$73.90K–

More Nu-Med Plus figures

See a number that looks wrong?